Nitrous Oxide Vasodilation Healthy Adult Volunteers



Status:Terminated
Conditions:Hot Flash, Other Indications, Hematology
Therapuetic Areas:Hematology, Other, Reproductive
Healthy:No
Age Range:19 - Any
Updated:1/18/2019
Start Date:February 2013
End Date:February 2017

Use our guide to learn which trials are right for you!

Peripheral Vasodilation in Healthy Adult Volunteers Receiving 50% Nitrous Oxide

Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during
painful medical procedures. However, one of its effects is to also make veins appear larger
and more visible. This is useful when there is a patient who needs to have an intravenous
(IV) needle put in their skin to give them medicine or fluids, but may have veins that are
very hard to see or feel. The mechanism of this observed effect is not entirely clear. The
purpose of this study is to use an ultrasound to directly measure whether there is an actual
change size of veins or change in blood flow in healthy adult volunteers when you give them
50% nitrous oxide, and see whether or not this change in size, or change in flow, is what
causes the changes in visibility or palpability of the vein.


Inclusion Criteria:

- Healthy adult volunteers.

- 19 years or older (inclusive)

- English speaking.

Exclusion Criteria:

- ASA class III or greater;

- History of, or suspected, difficult airway based on physical exam, facial dysmorphism
or syndrome

- Any condition in which air may be trapped in a body cavity. These include, but are not
limited to:

Pneumothorax or chest injury, concurrent acute asthma exacerbation, middle ear occlusion,
intestinal obstruction, ileus, or abdominal distension, sinusitis or maxillofacial injuries
with potential for trapped gas, recent intraocular surgery or penetrating globe injury, air
embolus, severe bullous emphysema (consider in patients with cystic fibrosis), history of
craniotomy in previous three weeks

- Pregnancy (1st and 2nd trimester)

- Increased intracranial pressure, impaired level of consciousness, or head injury

- Known Vitamin B12 deficiency

- Known MTHFR Deficiency (Inborn error of metabolism)

- History of bleomycin administration (note that the oxygen component of N2O
administration is what interacts with bleomycin to cause pulmonary toxicity)

- Intoxication with alcohol or other drugs

- Any condition in which patient may be catecholamine-depleted (e.g. septic shock)

- Recent history of altered mental status

- Pulmonary hypertension

- Congestive heart failure.

- Trainees, including students, residents, and fellows, working in the pediatric
emergency department.
We found this trial at
1
site
New York, New York 10032
Principal Investigator: Daniel S Tsze, MD, MPH
Phone: 212-305-9825
?
mi
from
New York, NY
Click here to add this to my saved trials